Singlera Genomics Inc

Invivoscribe Inc., headquartered in San Diego, CA, is a leading provider of personalized molecular medicine, offering a range of internationally standardized testing services for biomarkers essential to patient care. Their laboratory, LabPMM, specializes in next-generation sequencing and companion diagnostics, ensuring optimal treatment decisions through advanced molecular testing. Focused on enhancing healthcare quality, Invivoscribe's products include a variety of assays for hematological cancers, such as acute myeloid leukemia and lymphoma, along with a comprehensive testing menu. The company is committed to personalized medicine by utilizing genomics and patient-specific data to tailor treatments for individual needs. Generated from the website

Vala Sciences is a San Diego-based company specializing in screening services and innovative products for the fields of cardiology and neurology. Their cutting-edge technologies, such as the KIC Kinetic Image Cytometer and CyteSeer Automated Video Analysis Software, provide advanced solutions for toxicity and efficacy analysis. Vala Sciences also offers fully validated antibodies, reagents, screening kits, and hiPSC-derived cells, making them a comprehensive resource for researchers and scientists. With a focus on excellence, Vala Sciences has established centers of excellence and actively engages with the scientific community through publications, references, and NIH studies. Their commitment to advancing scientific knowledge is evident in their AI Deep Analytics for Toxicity Efficacy and SIM Structured Illumination Microscopy technologies. As a leader in the industry, Vala Sciences continues to provide innovative solutions for the challenges faced in the fields of cardiology and neurology.Generated from the website

SCLERA LLC is a privately held contract research organization based in San Diego, specializing in retinal pre-clinical studies using their patented intraocular implant technology to simulate experimental diabetic retinopathy and neovascular aging-related macular degeneration in rabbits and non-human primates. With a focus on accelerating the discovery of novel ophthalmic drugs, SCLERA LLC aims to improve, invent, and innovate in the field of ophthalmology, utilizing advanced techniques such as color fundus photography, fluorescein angiography, and immunohistochemical staining to study and analyze the effects of their implants on the retina.Generated from the website